SpaceX~$1TSpaceX~$1T
Insider Buying
Subscribe
All stock lists
EGHT

8x8 Inc /De/ (NASDAQ:EGHT)

US · Delayed Price · Currency is USD
Technology · Software - Application
2.20+0.07 (+3.29%)
 
Market cap
$318M
Health Score
Analyst consensus
Listed since
Jul 2, 1997
Website
Insider Score
––Not scored
EGHT Insider Score

Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.

EGHT analyst forecast

EGHT analyst consensus

Moderate Buy2 ratings
Buy 2 Hold 0 Sell 0

Based on each firm’s most recent rating in the last 3 months — one vote per firm, so a desk that reiterates weekly does not count three times.

EGHT 12-month price target

No published price targets in the last 12 months.

Best analysts covering EGHT

  • B. Riley Securities33%success rate · 3 calls
  • Rosenblatt26%success rate · 19 calls

Measured by us from each firm’s own rating dates and this stock’s split- and dividend-adjusted closes. How we calculate this.

EGHT analyst ratings

FirmPrice targetAction
—RosenblattBuy——Reiterated2026-09-10
—RosenblattBuy——Reiterated2026-08-05
—B. Riley SecuritiesBuy——Reiterated2026-08-05
—RosenblattBuy——Reiterated2026-05-20
—RosenblattBuy——Reiterated2026-02-05
—RosenblattBuy——Reiterated2025-11-05
—RosenblattBuy——Reiterated2025-08-21
—RosenblattBuy——Reiterated2025-08-06
—RosenblattBuy——Reiterated2025-05-20
—B. Riley SecuritiesBuy——Reiterated2025-05-14
—RosenblattBuy——Reiterated2025-04-24
—Wells FargoUnderweight——Reiterated2025-04-22
—Morgan StanleyUnderweight——Reiterated2025-04-16
—MizuhoUnderperform——Reiterated2025-04-15
—BarclaysEqual Weight——Reiterated2025-02-05
—NeedhamBuy——Reiterated2025-02-05
—RosenblattBuy——Reiterated2025-02-03
—Morgan StanleyUnderweight——Reiterated2024-12-18
—MizuhoUnderperform——Downgraded2024-12-13
—Wells FargoUnderweight——Reiterated2024-11-05
—MizuhoNeutral——Reiterated2024-11-05
—BarclaysEqual Weight——Reiterated2024-11-05
—RosenblattBuy——Reiterated2024-10-28
—B. Riley SecuritiesBuy——Reiterated2024-10-24
—RosenblattBuy——Reiterated2024-08-22
—BarclaysEqual Weight——Reiterated2024-08-09
—NeedhamBuy——Reiterated2024-08-09
—RosenblattBuy——Reiterated2024-08-07
—Wells FargoUnderweight——Reiterated2024-06-21
—Morgan StanleyUnderweight——Downgraded2024-06-14
—NeedhamBuy——Reiterated2024-05-20
—NeedhamBuy——Reiterated2024-05-09
—Morgan StanleyEqual Weight——Reiterated2024-04-17
—RosenblattBuy——Reiterated2024-03-18
—RosenblattBuy——Reiterated2024-02-01
—NeedhamBuy——Reiterated2024-02-01
—RosenblattBuy——Reiterated2024-01-18
—BarclaysEqual Weight——Reiterated2023-11-02
—NeedhamBuy——Reiterated2023-11-02
—Craig-HallumBuy——Upgraded2023-11-02
—Morgan StanleyEqual Weight——Reiterated2023-10-19
—RosenblattBuy——Reiterated2023-09-20
—RosenblattBuy——Reiterated2023-08-28
—MizuhoNeutral——Reiterated2023-08-14
—NeedhamBuy——Reiterated2023-08-10
—RosenblattBuy——Reiterated2023-08-09
—Craig-HallumHold——Downgraded2023-08-09
—RosenblattBuy——Reiterated2023-08-03
—RosenblattBuy——Reiterated2023-06-22
—NeedhamBuy——Reiterated2023-05-19
—RosenblattBuy——Reiterated2023-05-12
—Wells FargoUnderweight——Reiterated2023-05-12
—BarclaysOverweight——Reiterated2023-05-12
—WedbushNeutral——Reiterated2023-05-12
—NeedhamBuy——Reiterated2023-05-12
—Morgan StanleyEqual Weight——Reiterated2023-05-12
—RosenblattBuy——Reiterated2023-05-11
—RosenblattBuy——Reiterated2023-03-24
—Morgan StanleyEqual Weight——Reiterated2023-02-02
—NeedhamBuy——Reiterated2023-02-02

EGHT earnings vs. estimates

QuarterEPS est.EPS actualRevenue est.Revenue actual
2026-02-030.090.12$179.7M$185.1M
2026-05-190.070.11$181.1M$185.2M
2026-08-040.080.09$182.3M$190.0M
2026-11-040.080.00$187.6M$0
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.